Above all, I genuinely believe that NMP cares about the team and the company’s success. It’s not just about the return we generate. I can’t overstate how much that trust matters.
CEO SPOTLIGHTS
We partner with strong CEOs of high-growth businesses, and together we scale.
If I started another company, NMP is the first investor I would call.
NMP has added tremendous value beyond capital. They helped us put together a board of operators with $1B+ exits, guided us on our transition from services to SaaS, and supported us through the pandemic.
A lot of firms focused on the “buzz” while Noro-Moseley was focused on developing a sustainable economic model and a scalable, successful business.
Our Exits
Our exits represent over $4 billion in aggregate enterprise value since 2015
NMP Investment Criteria
We are actively investing in businesses that meet these key criteria
-
Year-over-year growth
50%+
-
Compelling unit economics
-
Target revenue run rate
$2M-20M
-
nmp target investment
$5-15m
-
SIGNIFICANT OPPORTUNITY FOR MARKET DISRUPTION
-
Minimal prior funding
< $20M
NMP Portfolio News
view all news-
April 9, 2024
Cariloop Secures $ 20 Million in Series C Funding to Accelerate Growth and Expand Caregiver Support Solutions
-
March 1, 2024
Red Canary Announces Record Fourth Quarter and Full Year Fiscal 2024 Results
-
February 29, 2024
Medix Infusion Announces the Appointment of Pavlos Pavlidis, Jr., President and Chief Operating Officer
-
February 13, 2024
Findhelp Ranked #1 “Best in KLAS” Social Determinants of Health Network for Third Consecutive Year
-
January 17, 2024
AllerVie Health Expands Patient Care to Chicago, Illinois, with Acquisition of Allergy & Asthma Associates of DuPage
-
January 10, 2024
Medix Infusion Secures 35 Million in Series B Led by Echo Health Ventures